Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06475976 · ClinicalTrials.gov registry record

Multidimensional Phenotype Classification in Grade 3 Bronchopulmonary Dysplasia

A clinical trial of Bronchopulmonary Dysplasia, sponsored by Children's Hospital of Philadelphia.

Recruiting
Registry status
130
Enrollment target
1
Study location

NCT06475976: Recruiting study of Bronchopulmonary Dysplasia, sponsored by Children's Hospital of Philadelphia.

NCT06475976 is a study of Bronchopulmonary Dysplasia that is actively recruiting participants, run by Children's Hospital of Philadelphia. The registered enrollment target is 130 participants, below the 232-participant average among 29 other Bronchopulmonary Dysplasia trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06475976, a study of Bronchopulmonary Dysplasia, is actively recruiting participants, sponsored by Children's Hospital of Philadelphia.

RECRUITING
Registry status
130 participants
Enrollment target
1
Study location

Study Summary

Bronchopulmonary Dysplasia (BPD), or chronic lung disease of prematurity, is the most consequential complication of preterm birth and is strong predictor of childhood pulmonary and neurodevelopmental disability, particularly in infants diagnosed with grade 3 BPD (ventilator dependence at 36 weeks' postmenstrual age), the most severe disease form. This study aims to (1) generate the first empirically defined phenotype classification system for grade 3 BPD developed using a rich array of objective and quantitative cardiopulmonary diagnostic, clinical, and biological data; and (2) define the association between phenotype subgroups and neurodevelopmental and respiratory outcomes through 2 years' corrected age.

Primary Outcome

The number and characteristics of phenotype subgroups will be empirically defined using cluster analyses applied to the collected cardiopulmonary diagnostic and clinical data. All recorded diagnostic and clinical information will be considered for inclusion in these analyses. Final study reports will indicate which diagnostic and clinical data were most associated with cluster classification. The strength of association between assigned cluster and neurodevelopmental and respiratory outcomes ass

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Chest computed tomography (CT) with angiography
  • DIAGNOSTIC_TEST Bronchoscopy with bronchoalveolar lavage
  • DIAGNOSTIC_TEST Echocardiography
  • DIAGNOSTIC_TEST 24 hour esophageal pH ("potential of hydrogen") - multichannel intraluminal impedance (MII) monitoring (reflux testing)

Study Locations (1)

Pennsylvania

  • Children's Hospital of Philadelphia - Philadelphia

Trial Details

FieldValue
Enrollment Target 130 participants
Start Date 2023-12-05
Est. Completion 2029-07-31
Children's Hospital of Philadelphia

431 total trials

What NCT06475976 shows while recruiting

NCT06475976 is an observational study that tracks outcomes without assigning an intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 232-participant average among 29 other Bronchopulmonary Dysplasia trials with a reported enrollment target (44% lower).

The record links to 1 condition, with Bronchopulmonary Dysplasia appearing as the primary indexed condition, and to 4 interventions - of which Chest computed tomography (CT) with angiography is the first listed.

NCT06475976 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06475976 about?

NCT06475976 is a clinical study titled "Multidimensional Phenotype Classification in Grade 3 Bronchopulmonary Dysplasia". Bronchopulmonary Dysplasia (BPD), or chronic lung disease of prematurity, is the most consequential complication of preterm birth and is strong predictor of childhood pulmonary and neurodevelopmental disability, particularly in infants diagnosed with grade 3 BPD (ventilator dependence at 36 weeks' p...

What is the current status of trial NCT06475976?

This trial is currently recruiting. The enrollment target is 130 participants. The study started on 2023-12-05. Estimated completion is 2029-07-31.

What conditions does trial NCT06475976 study?

This clinical trial studies the following conditions: Bronchopulmonary Dysplasia.

What interventions are being tested in trial NCT06475976?

The interventions under investigation include: Chest computed tomography (CT) with angiography (DIAGNOSTIC_TEST), Bronchoscopy with bronchoalveolar lavage (DIAGNOSTIC_TEST), Echocardiography (DIAGNOSTIC_TEST), 24 hour esophageal pH ("potential of hydrogen") - multichannel intraluminal impedance (MII) monitoring (reflux testing) (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06475976?

This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06475976 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bronchopulmonary Dysplasia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06475976's enrollment target sits among peer trials

130 15th of 29 higher than 15 of 29 other Bronchopulmonary Dysplasia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Bronchopulmonary Dysplasia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01492036 · 130 participants

    Long-Term Follow-Up of Recipient of Gene Transfer Research

  • NCT01631617 · 130 participants · Phase 2

    Effects of Treatments on Atopic Dermatitis

  • NCT02368041 · 130 participants

    Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure

  • NCT02604277 · 130 participants · NA

    Suicidal Behavior in Patients Diagnosed With Bipolar Disorder

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06475976, the US trial registry maintained by the National Library of Medicine. NCT06475976 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.